No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
887 |
4. Check minimum number of eventsNone |
887 |
5. Include endpointsNone |
887 |
6. Filter based on genotype QC (FinnGen only) |
787 |
Control definitions (FinnGen only)
- Control exclude
- F5_PERSOBEH
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F60
- Name in latin
- Personalitas anxifera
Similar endpoints
↥List of similar endpoints to
Anxious personality disorder
based on the number of shared cases.
Similar with more cases:
- Specific personality disorders
- Disorders of adult personality and behaviour
- Any mental disorder
- Psychiatric diseases
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6586 | 3244 | 3328 |
| Only index persons | 6345 | 3173 | 3172 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.09 | 0.09 |
| Only index persons | 0.12 | 0.12 | 0.12 |
| Median age at first event (years) | |||
| Whole population | 31.88 | 31.84 | 31.90 |
| Only index persons | 31.54 | 31.61 | 31.48 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 787 | 501 | 286 |
| Unadjusted period prevalence (%) | 0.16 | 0.18 | 0.13 |
| Median age at first event (years) | 34.51 | 34.75 | 34.08 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 820
- Matched controls
- 8200
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N05AH04
ATC
quetiapine; oral
13.5
322.7
532
990
F40.1
ICD-10 Finland
Social phobias
26.1
307.7
286
165
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
4503599627370496.0
307.7
785
*
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
20.6
307.7
344
278
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
27.3
307.7
318
186
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
18.1
307.7
340
309
N06AX16
ATC
venlafaxine; oral
12.1
295.4
450
747
F32.9
ICD-10 Finland
Depressive episode, unspecified
11.4
280.2
444
767
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
16.0
239.9
232
197
F34.1
ICD-10 Finland
Dysthymia
17.9
233.9
209
154
N05AX12
ATC
aripiprazole; systemic
15.5
229.4
225
195
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
13.5
224.9
246
253
N05AH03
ATC
olanzapine; systemic
12.1
211.7
250
286
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
9.1
194.3
310
515
N06AX12
ATC
bupropion; oral
9.4
193.3
292
455
N06AB06
ATC
sertraline; oral
8.2
188.0
344
663
N06AB04
ATC
citalopram; systemic
7.6
181.6
376
821
F60.5
ICD-10 Finland
Anankastic personality disorder
58.4
173.2
98
19
N06AB03
ATC
fluoxetine; oral
8.2
166.3
283
498
N05AX08
ATC
risperidone; systemic
11.2
165.7
199
229
P76
ICPC
Depressive disorder
8.3
158.5
257
427
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
7.1
151.5
304
630
N06AB10
ATC
escitalopram; oral
6.2
151.4
457
1384
N06AX26
ATC
vortioxetine; oral
7.6
143.3
251
450
N06AX11
ATC
mirtazapine; oral
5.9
138.9
512
1811
N05BA04
ATC
oxazepam; oral
5.7
134.6
419
1278
N03AX09
ATC
lamotrigine; oral
9.6
133.6
176
226
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
12.6
126.8
133
124
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
40.4
125.3
77
21
F41.1
ICD-10 Finland
Generalized anxiety disorder
7.2
124.4
224
409
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
10.0
121.8
153
184
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
22.2
113.9
86
43
N05AB03
ATC
perphenazine; systemic, rectal
14.3
113.2
108
86
T36
ICD-10 Finland
Poisoning by systemic antibiotics
10.7
110.8
130
142
N06AX21
ATC
duloxetine; oral
6.1
110.1
240
524
N06AG02
ATC
moclobemide; oral
12.6
108.0
112
102
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
14.0
107.1
103
83
F61.0
ICD-10 Finland
Mixed personality disorders
+∞
106.6
100
*
ZY010
NOMESCO Finland
Hospital outpatient
7.8
104.8
163
252
P03
ICPC
Feeling depressed
5.2
104.7
296
808
IGY02
NOMESCO Finland
Psychiatric monitoring contact
9.6
104.3
133
162
N05AA02
ATC
levomepromazine; systemic
13.6
103.9
102
85
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
387.8
102.6
101
*
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
12.3
102.0
107
99
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
9.3
99.9
131
165
N06AX03
ATC
mianserin; oral
11.2
98.2
110
112
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
4.8
96.5
298
867
N06AB05
ATC
paroxetine; oral
8.1
96.3
143
209
P99
ICPC
Psychological disorders other
9.6
96.2
122
147
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
11.2
95.2
106
107
SPAT1240
SPAT
Therapeutic discussion
4.9
90.8
262
718
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
488.8
90.0
88
*
P01
ICPC
Feeling anxious/nervous/tense
4.3
89.7
349
1200
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
11.1
89.6
100
101
F29
ICD-10 Finland
Unspecified nonorganic psychosis
8.1
87.1
127
181
P29
ICPC
Psychological sympt/compl other
5.1
85.6
222
555
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
8.8
81.8
110
142
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
10.5
81.0
94
100
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
6.4
76.8
141
256
N06AX22
ATC
agomelatine; oral
10.3
76.8
90
97
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
10.2
76.2
90
98
N05BE01
ATC
buspirone; oral
10.3
75.9
89
96
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
9.9
75.4
91
102
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
7.9
75.0
110
157
C07AA05
ATC
propranolol; systemic
3.8
72.6
320
1173
Z2445
NOMESCO Finland
Psychologist
7.2
71.3
114
179
N05AN01
ATC
lithium; oral
11.2
69.5
76
74
N05AF03
ATC
chlorprothixene; systemic
12.9
68.5
68
57
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
23.1
68.0
50
23
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
4.0
67.1
252
822
N06AX05
ATC
trazodone; oral
11.3
64.7
70
67
F60.9
ICD-10 Finland
Personality disorder, unspecified
145.7
63.9
67
5
N03AE01
ATC
clonazepam; systemic
7.4
63.7
98
147
AA400
NOMESCO Finland
Electroconvulsive therapy
23.7
62.0
45
20
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
16.6
62.0
53
34
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
26.6
61.8
43
17
SPAT1307
SPAT
Psychosocial counselling and guidance
4.5
61.7
177
471
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
9.4
61.2
76
88
N05BA01
ATC
diazepam; systemic, rectal
4.6
60.7
170
444
F60.8
ICD-10 Finland
Other specific personality disorders
219.3
59.9
61
*
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
11.5
59.0
63
59
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
5.9
58.6
114
217
F60.0
ICD-10 Finland
Paranoid personality disorder
609.5
58.4
57
*
N03AG01
ATC
valproic acid; systemic, rectal
6.0
58.0
111
208
P74
ICPC
Anxiety disorder/anxiety state
5.0
58.0
142
332
N05BA06
ATC
lorazepam; systemic, sublingual
7.7
57.4
85
122
IGY99
NOMESCO Finland
Other psychiatric treatment contact
8.5
56.6
76
97
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
9.2
56.2
71
84
Z2446
NOMESCO Finland
Social worker
5.5
55.4
118
244
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
6.4
55.3
98
170
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.4
55.1
119
249
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
7.5
54.7
82
119
N05CD07
ATC
temazepam; oral
5.8
54.2
108
210
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
6.1
54.0
101
185
F10.20
ICD-10 Finland
Alcohol dependence currently independent
12.5
53.7
54
46
N05CF01
ATC
zopiclone; oral
3.2
52.3
301
1262
F43.1
ICD-10 Finland
Post-traumatic stress disorder
6.3
51.6
93
164
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
9.4
51.1
63
72
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
10.3
50.6
58
60
F60.1
ICD-10 Finland
Schizoid personality disorder
+∞
49.5
47
*
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
5.3
48.9
108
230
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
12.1
47.7
49
43
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
8.9
47.7
61
73
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
11.0
45.9
50
48
IGY02, ,
SPAT
9.2
45.7
57
66
N05AH02
ATC
clozapine; systemic
9.0
45.6
58
69
F60.7
ICD-10 Finland
Dependent personality disorder
+∞
45.2
43
*
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.8
44.6
87
165
F99
ICD-10 Finland
Mental disorder, not otherwise specified
8.0
44.2
62
83
N07BB01
ATC
disulfiram; oral
6.0
44.0
82
149
F31.8
ICD-10 Finland
Other bipolar affective disorders
8.1
43.8
61
81
F33.8
ICD-10 Finland
Other recurrent depressive disorders
13.4
43.7
42
33
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
5.4
43.2
92
189
P72
ICPC
Schizophrenia
8.2
41.7
57
74
IGV01
NOMESCO Finland
Psychiatric network contact
11.9
41.6
43
38
F50.9
ICD-10 Finland
Eating disorder, unspecified
10.3
41.3
47
48
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
8.8
41.1
53
64
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
5.1
40.5
91
196
3018C
ICD-9 Finland
Personality disorders, Other personality disorders[ESTYNYT PERSOONALLISUUS]
+∞
39.9
38
*
N05AL01
ATC
sulpiride; systemic
15.2
39.3
35
24
N06AB08
ATC
fluvoxamine; oral
9.5
39.0
47
52
ZYC01
NOMESCO Finland
Remote contact by phone
4.3
38.1
108
280
F39
ICD-10 Finland
Unspecified mood [affective] disorder
7.1
37.8
59
89
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
73.5
37.3
42
6
F33
ICD-10 Finland
Recurrent depressive disorder
5.9
37.0
69
125
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.0
36.5
84
184
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
11.0
36.0
39
37
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
11.3
35.8
38
35
P80
ICPC
Personality disorder
362.0
35.2
35
*
F84.5
ICD-10 Finland
Asperger syndrome
10.4
34.7
39
39
N05AD01
ATC
haloperidol; systemic
10.0
34.4
40
42
N05AF01
ATC
flupentixol; systemic
13.2
34.2
33
26
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
13.8
34.1
32
24
SPAT1234
SPAT
Support of social functional capacity
5.9
33.0
62
113
N05BA12
ATC
alprazolam; oral
3.6
32.7
122
383
F41.00
ICD-10 Finland
Moderate panic disorder
6.8
32.3
52
81
IHZ05, ,
SPAT
3.7
30.9
109
329
N03AX16
ATC
[U] pregabalin
2.7
30.7
201
871
F20.9
ICD-10 Finland
Schizophrenia, unspecified
7.2
30.4
46
67
F32
ICD-10 Finland
Depressive episode
3.8
30.2
101
294
N06AA09
ATC
amitriptyline; systemic
4.1
30.1
89
237
OAB43, ,
SPAT
0.4
30.0
163
3319
F32.8
ICD-10 Finland
Other depressive episodes
7.4
29.9
44
62
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
7.2
29.5
45
66
N06AA12
ATC
doxepin; systemic
5.5
29.5
59
114
F50.2
ICD-10 Finland
Bulimia nervosa
11.5
29.5
31
28
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
11.5
29.5
31
28
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
11.1
28.8
31
29
P06
ICPC
Sleep disturbance
2.7
28.7
181
767
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
6.6
28.5
47
75
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
3.5
27.9
103
320
N05CF02
ATC
zolpidem; oral
2.7
27.3
176
753
IEY01
NOMESCO Finland
Psychoeducation, individual
9.5
26.6
32
35
SPAT1243
SPAT
Psychiatric/psychological examination
4.7
26.6
64
145
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
8.0
26.1
36
47
IHZ04, ,
SPAT
5.7
26.0
50
93
IER01
NOMESCO Finland
Psychoeducation, group
10.7
25.5
28
27
P28
ICPC
Limited function/disability (P)
9.7
25.4
30
32
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
5.7
25.3
48
88
IBA03
NOMESCO Finland
Psychotherapy evaluation
7.2
25.2
38
55
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
7.3
24.8
37
53
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.4
24.5
95
304
F41.09
ICD-10 Finland
UNS Panic Syndrome
4.1
24.3
69
178
N06AX18
ATC
reboxetine; oral
23.6
24.1
34
15
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
8.0
23.9
33
43
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.6
23.9
156
668
Z3231
NOMESCO Finland
Registered nurse
2.3
23.7
236
1226
F64.9
ICD-10 Finland
Gender identity disorder, unspecified
+∞
23.0
22
*
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
6.1
22.8
40
68
N05BA02
ATC
chlordiazepoxide; systemic
8.0
22.7
31
40
N02BF02
ATC
pregabalin; oral
3.5
22.3
80
243
ICB06, ,
NOMESCO Finland
20.2
22.3
33
17
F32.1
ICD-10 Finland
Moderate depressive episode
2.9
21.5
115
443
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
9.2
21.3
26
29
F21
ICD-10 Finland
Schizotypal disorder
25.0
21.0
29
12
IEV99
NOMESCO Finland
Other psychiatric network intervention
20.1
21.0
31
16
N06AA04
ATC
clomipramine; systemic
8.0
20.5
28
36
N05AC02
ATC
thioridazine; oral
6.3
20.4
35
58
L17
ICPC
Foot/toe symptom/complaint
2.1
20.0
270
1566
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.6
19.9
131
560
P27
ICPC
Fear of mental disorder
5.9
19.9
36
63
IBZ08
NOMESCO Finland
Gender identity assessment
+∞
19.9
19
*
ZY000
NOMESCO Finland
Hospital inpatient
6.4
19.9
33
53
F61
ICD-10 Finland
Mixed and other personality disorders
75.4
19.8
22
*
F50.1
ICD-10 Finland
Atypical anorexia nervosa
8.4
19.7
26
32
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
20.0
19.6
29
15
N06AA06
ATC
trimipramine; systemic
5.8
19.6
36
64
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.4
19.4
75
239
F93.89
ICD-10 Finland
Other childhood emotional disorders
8.1
19.2
26
33
SPAT1241
SPAT
Extensive assessment of psychosocial situation
6.2
19.2
33
55
F40.00
ICD-10 Finland
Agoraphobia without concomitant panic disorder
23.2
19.2
27
12
IHZ07, ,
SPAT
16.3
18.9
30
19
F50.0
ICD-10 Finland
Anorexia nervosa
7.9
18.8
26
34
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.7
18.4
109
442
F31
ICD-10 Finland
Bipolar affective disorder
7.0
18.3
28
41
N04AA02
ATC
biperiden; systemic
7.0
18.3
28
41
IFB02
NOMESCO Finland
Transcranial magnetic stimulation (TMS)
19.9
18.3
27
14
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
6.2
17.9
31
52
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.7
17.8
104
418
F41.3
ICD-10 Finland
Other mixed anxiety disorders
4.5
17.8
44
102
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
6.3
17.8
30
49
H03AA01
ATC
levothyroxine sodium; systemic
2.2
17.7
187
981
N06AX17
ATC
milnacipran; oral
16.1
17.6
28
18
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
6.7
17.6
28
43
SPAT1301
SPAT
No procedures
2.0
17.3
258
1538
P15
ICPC
Chronic alcohol abuse
4.1
17.2
48
122
T82
ICPC
Obesity
3.4
17.2
63
194
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
17.1
192
1031
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
7.0
17.1
26
38
F10.24
ICD-10 Finland
Alcohol depence active use
6.4
16.8
28
45
A06AD11
ATC
lactulose; oral
2.9
16.6
83
307
N05AE04
ATC
ziprasidone; systemic
13.8
16.6
28
21
N05AD03
ATC
melperone; systemic
25.1
16.1
22
9
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
21.5
16.0
23
11
Z08
ICPC
Social welfare problem
6.5
15.9
26
41
F51.0
ICD-10 Finland
Nonorganic insomnia
2.0
15.8
209
1189
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
7.4
15.7
23
32
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
+∞
15.7
15
*
N05AE05
ATC
lurasidone; oral
19.7
15.6
23
12
SPAT1216
SPAT
Assessment of functional ability
2.7
15.4
91
367
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
5.8
15.2
28
50
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.5
15.0
52
154
A04
ICPC
Weakness/tiredness general
2.1
15.0
162
853
SPAT1389
SPAT
Visit based on need for special support
3.5
14.9
53
160
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.3
14.8
124
588
A29
ICPC
General symptom/complaint other
2.4
14.5
111
507
F50.3
ICD-10 Finland
Atypical bulimia nervosa
13.7
14.3
24
18
E66.8
ICD-10 Finland
Other obesity
2.9
14.3
71
262
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.8
14.2
277
1782
Z06
ICPC
Unemployment problem
6.5
14.2
23
36
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.9
14.1
69
252
SPAT1252
SPAT
Overall medication plan or its review
3.6
14.1
47
136
R02
ICPC
Shortness of breath/dyspnoea
2.3
14.0
112
521
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
6.6
13.7
22
34
F64.0
ICD-10 Finland
Transsexualism
+∞
13.6
13
*
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.3
13.5
27
52
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
16.5
13.5
21
13
N05AX16
ATC
brexpiprazole; oral
16.5
13.5
21
13
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
13.5
191
1106
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
26.2
13.4
18
7
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.6
13.3
82
338
F10.25
ICD-10 Finland
Alcohol dependence continuous use
5.9
13.3
24
42
SPAT1395
SPAT
Health check-up of persons outside student and working life
4.5
13.2
32
73
A01
ICPC
Pain general/multiple sites
2.4
13.2
94
415
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.4
13.0
91
1831
R96
ICPC
Asthma
2.5
12.9
82
343
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
50.8
12.9
15
*
K59.0
ICD-10 Finland
Constipation
3.4
12.8
47
145
IER05
NOMESCO Finland
Rehabilitative psychiatric group intervention, social skills
71.0
12.6
14
*
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.5
12.4
79
331
OAA67, ,
SPAT
0.4
12.3
62
1433
F22.0
ICD-10 Finland
Delusional disorder
10.7
12.3
23
22
G47.3
ICD-10 Finland
Sleep apnoea
1.9
12.2
175
1014
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.8
12.2
258
1687
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
6.1
12.2
21
35
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.2
12.1
32
78
F41.08
ICD-10 Finland
Mild or other specified panic syndrome
11.3
12.1
22
20
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.5
12.0
29
66
N05AX15
ATC
cariprazine; oral
13.6
12.0
20
15
X78
ICD-10 Finland
Intentional self-harm by sharp object
11.9
11.9
21
18
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.8
11.9
61
229
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
11.7
183
1089
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.9
11.7
55
197
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
11.6
171
998
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
23.3
11.6
16
7
SPAT1263
SPAT
Sampling
1.7
11.5
345
2476
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
11.5
68
275
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
11.4
111
559
SPAT1310
SPAT
Counselling related to known health issue
1.7
11.3
268
1802
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
4.1
11.3
31
78
OAA68, ,
SPAT
4.7
11.2
26
57
S18
ICPC
Laceration/cut
1.7
11.2
337
2413
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
17.3
11.2
17
10
P58
ICPC
Psychological, Therapeutic counselling/listening
3.4
11.2
41
126
D12
ICPC
Constipation
4.2
11.2
30
74
SPAT1260
SPAT
Consultation of another employee
2.0
11.1
136
744
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
10.2
11.0
21
21
N06BA04
ATC
methylphenidate; oral
2.5
11.0
70
293
A27
ICPC
Fear of other disease NOS
3.1
10.9
45
149
C07AB07
ATC
bisoprolol; oral
1.7
10.9
250
1662
SPAT1238
SPAT
Brief therapy
4.0
10.9
31
80
A28
ICPC
Limited function/disability NOS
2.5
10.9
74
319
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
15.7
10.9
17
11
P20
ICPC
Memory disturbance
3.1
10.8
46
155
F33.0
ICD-10 Finland
Recurrent depressive disorder, current episode mild
5.2
10.8
22
43
N05AA01
ATC
chlorpromazine; systemic, rectal
10.8
10.8
20
19
M79.7
ICD-10 Finland
Fibromyalgia
3.3
10.8
40
124
SPAT1284
SPAT
Extensive health certificate
3.4
10.8
38
114
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
28.4
10.7
14
5
D01
ICPC
Abdominal pain/cramps general
2.0
10.7
134
738
L28
ICPC
Limited function/disability (L)
2.2
10.7
100
494
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.2
10.7
42
135
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.5
10.7
97
1795
U05
ICPC
Urination problems other
3.5
10.7
37
110
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
11.4
10.6
19
17
IBA01, ,
SPAT
3.3
10.5
39
121
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
14.4
10.5
17
12
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
12.2
10.4
18
15
N03AX12
ATC
[U] gabapentin; oral
2.1
10.4
113
593
W78
ICPC
Pregnancy
0.4
10.2
73
1477
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
3.8
10.2
31
84
Z3226
NOMESCO Finland
Physiotherapist
2.0
10.2
128
706
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.6
10.1
61
249
EBA00
NOMESCO Finland
Extraction of tooth
1.6
10.0
343
2519
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.8
10.0
184
1145
A11
ICPC
Chest pain NOS
2.6
10.0
61
250
SPAT1097
SPAT
Recording of ECG
2.3
9.9
81
379
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
17.0
9.9
15
9
P86
ICPC
Anorexia nervosa/bulimia
12.4
9.9
17
14
F40.2
ICD-10 Finland
Specific (isolated) phobias
5.2
9.9
20
39
R4110, ,
SPAT
2.1
9.8
96
483
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
20.3
9.8
14
7
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
8.9
9.8
20
23
ZXY60
NOMESCO Finland
2-person team, nurses
10.8
9.8
18
17
T90
ICPC
Diabetes non-insulin dependent
1.9
9.8
126
700
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
13.6
9.7
16
12
IFB04
NOMESCO Finland
Transcranial direct current stimulation (tDCS)
55.7
9.7
11
*
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
8.0
9.7
21
27
A10BA02
ATC
metformin; oral
1.8
9.6
155
926
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.1
9.6
91
452
U02
ICPC
Urinary frequency/urgency
1.9
9.6
122
676
SPAT1197
SPAT
Extensive health check-up of expecting family
0.4
9.5
52
1173
S21
ICPC
Skin texture symptom/complaint
1.9
9.4
124
695
F60.2
ICD-10 Finland
Dissocial personality disorder
+∞
9.4
9
*
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
12.5
9.4
16
13
SPAT1254
SPAT
Administration of medicine
1.9
9.3
119
659
P98
ICPC
Psychosis NOS/other
8.8
9.3
19
22
N05AB01
ATC
dixyrazine; systemic
10.8
9.3
17
16
WZC00, ,
SPAT
1.9
9.2
139
813
-45
ICPC
Observ/health educat/advice/diet
3.8
9.2
28
76
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
13.9
9.2
15
11
F28
ICD-10 Finland
Other nonorganic psychotic disorders
13.9
9.2
15
11
IEY15
NOMESCO Finland
Acute psychiatry, stabilising intervention
15.8
9.1
14
9
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
15.8
9.1
14
9
F50.8
ICD-10 Finland
Other eating disorders
10.2
9.1
17
17
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
10.2
9.1
17
17
N03AX11
ATC
topiramate; oral
3.3
9.0
34
107
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.1
9.0
37
123
ZXY61
NOMESCO Finland
2-person team, special workers
18.8
9.0
13
7
Z3229
NOMESCO Finland
Other healthcare associate professional
2.6
8.9
53
215
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
6.9
8.9
21
31
T83
ICPC
Overweight
3.6
8.9
29
83
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
8.7
8.8
18
21
SFA10
NOMESCO Finland
One-surface restoration
1.6
8.8
499
4079
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
8.8
315
2321
H13
ICPC
Plugged feeling ear
1.9
8.8
123
703
A05
ICPC
Feeling ill
2.1
8.7
91
469
IEY03
NOMESCO Finland
Vocational rehabilitation
14.2
8.7
14
10
AA1AD
NOMESCO Finland
CT of head and brain
1.8
8.7
154
946
N06BA12
ATC
lisdexamfetamine; oral
3.6
8.6
28
80
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
10.2
8.6
16
16
N05AF05
ATC
zuclopenthixol; systemic
10.2
8.6
16
16
E66.01
ICD-10 Finland
Obesity due to excess calories
2.0
8.5
102
552
P19
ICPC
Drug abuse
6.5
8.5
21
33
OAA80, ,
SPAT
0.3
8.5
32
856
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.5
8.5
98
1695
WX290
NOMESCO Finland
Other blockage of nerve
1.6
8.5
482
3926
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
8.4
69
323
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.9
8.4
38
133
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.8
8.3
138
830
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
3.2
8.3
32
102
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.7
8.3
196
1301
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.1
8.3
79
394
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.4
8.3
53
1126
SPAT1058
SPAT
PEF monitoring instruction
2.4
8.2
59
261
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
6.6
8.2
20
31
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
6.6
8.2
20
31
OAB72, ,
SPAT
4.0
8.2
23
59
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.5
8.2
457
3697
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
8.1
627
5452
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.1
8.1
83
425
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
6.9
8.1
19
28
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
11.8
8.1
14
12
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
11.8
8.1
14
12
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
33.7
8.1
10
*
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
17.4
8.1
12
7
ICB03, ,
SPAT
10.2
8.1
15
15
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.0
8.0
94
505
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
22.3
8.0
11
5
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
8.0
396
3114
K59.09
ICD-10 Finland
Constipation, unspecified
2.7
8.0
42
160
Z2221
NOMESCO Finland
Medical doctor
1.6
8.0
203
1372
K08.3
ICD-10 Finland
Retained dental root
2.4
8.0
54
233
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.8
7.9
24
65
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
7.9
300
2226
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
13.2
7.9
13
10
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
7.8
367
2849
WVA30, ,
SPAT
2.5
7.7
50
211
F10.09
ICD-10 Finland
Alcohol intoxication UNS
3.6
7.7
25
71
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.5
7.7
46
187
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
7.7
138
849
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.6
7.7
186
1241
SPAT1360
SPAT
Extensive global examination
2.5
7.6
48
200
SPAT1053
SPAT
Memory test
2.9
7.6
35
124
Z91.5
ICD-10 Finland
Personal history of self-harm
18.6
7.6
11
6
N05BA05
ATC
potassium clorazepate; oral
12.0
7.6
13
11
T07
ICPC
Weight gain
3.5
7.6
26
77
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.5
7.6
64
1231
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
9.0
7.6
15
17
F45.0
ICD-10 Finland
Somatization disorder
10.2
7.5
14
14
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
7.5
637
5596
N03AF01
ATC
carbamazepine; oral, rectal
2.9
7.5
35
125
K02.1
ICD-10 Finland
Caries of dentine
1.5
7.5
541
4584
30088
ICD-8 Finland
Neuroses, Other
80.8
7.4
8
*
WX725
NOMESCO Finland
Noninvasive ventilation
2.4
7.4
48
203
A02BC05
ATC
esomeprazole; systemic
1.5
7.4
269
1972
SPAT1285
SPAT
Provision of consultation response
2.6
7.4
43
173
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.6
7.4
43
173
SPAT1246
SPAT
Screening of depression or other psychiatric problem
2.2
7.4
63
301
R53
ICD-10 Finland
Malaise and fatigue
1.6
7.3
205
1415
P18
ICPC
Medication abuse
6.9
7.3
17
25
IAZ98
NOMESCO Finland
Other internal psychiatric consultation
9.5
7.3
14
15
3041A
ICD-9 Finland
Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence
+∞
7.3
7
*
Z29
ICPC
Social problem NOS
3.5
7.3
25
74
R06.0
ICD-10 Finland
Dyspnoea
1.6
7.3
172
1139
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
5.9
7.2
19
33
R11
ICD-10 Finland
Nausea and vomiting
2.0
7.2
80
421
IAA01, ,
SPAT
4.4
7.2
18
42
KMAK, ,
NOMESCO Finland
1.5
7.2
444
3624
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.4
7.2
49
212
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.5
7.2
58
1136
SPAT1081
SPAT
Cardiorespiratory global assessment
3.3
7.2
27
85
N05AC01
ATC
periciazine; systemic
30.3
7.2
9
*
3004A
ICD-9 Finland
Neurotic disorders, Neurotic depression
30.3
7.2
9
*
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
30.3
7.2
9
*
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
20.2
7.1
10
5
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.8
7.1
109
639
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
12.2
7.1
12
10
F33.01
ICD-10 Finland
Recurrent depression, mild episode of somatic syndrome
8.9
7.1
14
16
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
3.9
7.0
20
52
A02BC03
ATC
lansoprazole; oral
1.7
7.0
160
1050
WX882
NOMESCO Finland
High dependency care
4.0
6.9
19
48
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.5
6.9
53
1057
X84
ICD-10 Finland
Intentional self-harm by unspecified means
13.9
6.9
11
8
ZXY53
NOMESCO Finland
2-person team, doctor-social worker
13.9
6.9
11
8
IDY02
NOMESCO Finland
Systematic individual therapy, cognitive
13.9
6.9
11
8
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
13.9
6.9
11
8
SPAT1312
SPAT
General health counselling
1.5
6.9
262
1934
SPAT1100
SPAT
Long-term monitoring of blood pressure
3.3
6.9
25
77
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
8.4
6.8
14
17
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.7
6.8
125
772
SPAT1379
SPAT
Health check-up of pregnant person
0.5
6.8
49
1002
Z03
ICPC
Housing/neighbourhood problem
9.4
6.8
13
14
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.5
6.8
87
1470
IGY99, ,
SPAT
2.5
6.8
41
168
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.5
6.8
41
168
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
6.8
112
672
IDY04
NOMESCO Finland
Systematic individual therapy, dialectical behaviour therapy (DBT)
40.4
6.8
8
*
Z2230
NOMESCO Finland
Head nurse
40.4
6.8
8
*
L02
ICPC
Back symptom/complaint
1.8
6.8
103
603
MA3AE
NOMESCO Finland
Combined first trimester screening
0.3
6.8
15
529
IEZ99, ,
SPAT
16.9
6.8
10
6
S10
ICPC
Boil/carbuncle
2.2
6.7
54
252
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.4
6.7
30
742
RT250, ,
NOMESCO Finland
22.7
6.7
9
*
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
22.7
6.7
9
*
L03
ICPC
Low back symptom/complaint
1.5
6.7
242
1766
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.1
6.7
64
320
ICB01, ,
SPAT
6.5
6.7
16
25
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
6.5
6.7
16
25
V03AA01, ,
ATC
7.9
6.6
14
18
B03BA03
ATC
hydroxocobalamin; parenteral
3.0
6.6
28
95
IDY99
NOMESCO Finland
Other individual psychotherapy intervention
12.4
6.6
11
9
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
8.8
6.6
13
15
IAZ99
NOMESCO Finland
Other psychiatric consultation
10.1
6.5
12
12
S22
ICPC
Nail symptom/complaint
2.1
6.5
59
288
SFA30
NOMESCO Finland
Three-surface restoration
1.5
6.5
309
2381
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
0.4
6.5
34
788
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
6.3
6.5
16
26
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
5.8
6.5
17
30
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.1
6.5
62
310
N06AA10
ATC
nortriptyline; systemic
3.5
6.5
22
65
SPAT1380
SPAT
Postpartum check-up
0.4
6.4
37
825
U01
ICPC
Dysuria/painful urination
2.0
6.4
73
388
F20
ICD-10 Finland
Schizophrenia
7.5
6.4
14
19
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.3
6.4
46
204
SPAT1370
SPAT
Other health check-up
2.8
6.4
32
119
Z28
ICPC
Limited function/disability (Z)
14.4
6.4
10
7
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.7
6.4
378
4541
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.1
6.3
57
278
RS220, ,
NOMESCO Finland
6.0
6.3
16
27
A62
ICPC
General and Unspecified, Administrative procedure
3.5
6.3
21
61
RD210, ,
NOMESCO Finland
3.5
6.3
21
61
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
11.1
6.3
11
10
ZXY03
NOMESCO Finland
Occupational therapist
9.3
6.3
12
13
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.3
6.3
18
553
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.5
6.3
39
162
IHZ04
NOMESCO Finland
Psychosocial counselling and guidance
18.2
6.3
9
5
S01
ICPC
Pain/tenderness of skin
2.6
6.3
36
144
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
6.3
268
2020
F64.8
ICD-10 Finland
Other gender identity disorders
+∞
6.3
6
*
IAB05
NOMESCO Finland
Psychiatric consultation for gender identity assessment
+∞
6.3
6
*
30188
ICD-8 Finland
Personality disorders, Alia definita
+∞
6.3
6
*
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.1
6.2
25
82
U04
ICPC
Incontinence urine
2.9
6.2
29
104
B18.2
ICD-10 Finland
Chronic viral hepatitis C
5.1
6.2
18
36
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
6.2
167
1138
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
6.3
6.2
15
24
H70
ICPC
Otitis externa
3.4
6.2
21
62
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.3
6.2
46
208
L12
ICPC
Hand/finger symptom/complaint
1.6
6.2
146
965
N05AX13
ATC
paliperidone; systemic
7.8
6.1
13
17
SPAT1281
SPAT
Other administrative function
2.0
6.1
63
324
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
8.7
6.1
12
14
XA800
NOMESCO Finland
Neuropsychological investigation
2.4
6.1
39
165
Z27
ICPC
Fear of a social problem
6.8
6.1
14
21
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
10.1
6.0
11
11
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.5
6.0
38
159
L29
ICPC
Musculoskeletal sympt/complt other
2.0
6.0
65
340
WX003
NOMESCO Finland
Sedation or analgesia orally, rectally or intramuscularly without general anesthesia
3.9
6.0
17
44
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
322
1168
3.89
74.48
2.4
1.8
1.60
1.40
%
4.50
295
1063
215
665
4.03
61.17
1.7
1.6
1065.17
1154.65
nmol/l
0.77
179
525
465
2429
3.11
55.53
2.3
1.8
97.60
97.66
pmol/l
0.01
269
1313
327
1464
3.05
50.32
1.7
1.5
19.19
20.39
nmol/l
0.75
298
1297
481
2660
2.96
50.06
6.7
6.4
1.21
1.21
mmol/l
0.28
431
2330
441
2339
2.92
49.44
6.5
5.8
1.21
1.21
mmol/l
0.53
412
2185
361
1917
2.58
37.53
2.7
3.0
2.35
2.35
mmol/l
0.10
336
1789
422
2430
2.52
36.66
5.3
4.6
37.53
37.36
g/l
0.26
391
2307
736
5613
4.04
36.23
5.9
4.2
14.21
14.46
pmol/l
2.42
703
5252
418
2426
2.47
35.29
4.7
3.2
29.45
30.82
u/l
0.45
397
2315
359
1963
2.47
34.30
3.4
3.4
7.56
8.55
mmol/l
3.11
320
1742
128
406
3.55
33.79
2.2
1.7
0.19
0.27
mg/l
1.47
48
196
475
2980
2.41
32.90
3.1
2.5
70.13
72.85
nmol/l
1.23
455
2791
649
4814
2.67
29.29
8.3
7.1
74.03
73.87
u/l
0.04
619
4599
309
1687
2.33
28.44
3.7
3.1
1.02
1.02
kg/l
0.46
204
1069
766
6361
4.10
25.42
5.8
3.7
5.85
5.69
mmol/l
2.33
729
6007
284
1567
2.24
24.83
2.5
2.1
2.44
2.58
mg/l
0.66
245
1364
159
676
2.68
24.77
1.7
2.0
363.63
382.20
nmol/l
0.55
147
636
776
6544
4.46
24.18
7.5
5.0
1.74
1.78
mu/l
0.52
750
6248
788
6732
5.37
23.78
18.4
11.3
139.65
139.64
mmol/l
0.05
772
6586
788
6749
5.29
23.30
18.4
11.4
3.89
3.92
mmol/l
3.43
768
6585
211
1061
2.33
22.74
1.8
1.6
415.43
31694989.94
pmol/l
1.24
184
956
154
676
2.57
22.33
5.4
5.9
1.06
1.04
mmol/l
0.45
142
630
49
104
4.95
22.00
2.4
2.1
—
—
—
0
0
319
1951
2.04
20.53
3.5
2.5
67.66
60.69
u/l
0.21
295
1834
669
5346
2.37
20.49
4.9
3.0
38.85
36.95
u/l
0.47
647
5161
446
3154
1.91
18.03
6.0
5.6
10.03
10.56
umol/l
0.37
426
2997
165
837
2.22
16.93
2.4
2.3
2.47
2.43
g/l
0.36
146
781
488
3610
1.87
16.56
5.7
4.5
6.40
6.38
mmol/l
0.06
459
3299
168
885
2.13
15.57
3.3
3.2
0.82
0.82
mmol/l
0.26
156
845
169
896
2.12
15.39
2.7
2.3
15.01
14.59
umol/l
0.29
159
843
27
25
11.13
14.57
7.5
1.7
149.07
167.73
umol/l
0.09
15
11
609
4942
1.90
14.27
4.6
3.8
10.61
8.54
mm/h
3.81
578
4674
176
972
2.03
14.27
2.3
2.3
2.42
2.42
mmol/l
0.19
159
863
262
1657
1.85
14.17
2.6
2.0
185.71
202.50
u/l
0.15
248
1591
507
3898
1.79
14.11
12.9
8.9
3.99
4.01
e9/l
0.10
438
3436
507
3902
1.78
14.01
3.6
3.1
78.47
85.71
ug/l
0.57
482
3742
109
505
2.34
13.73
2.8
2.4
0.22
0.23
g/l
0.81
95
479
143
748
2.10
13.36
2.4
2.4
25.97
24.07
%
0.72
136
707
105
485
2.34
13.31
8.0
9.9
1.70
0.66
mmol/l
2.12
88
393
308
2109
1.74
12.41
1.4
1.3
2.68
1.88
u/ml
0.21
66
604
802
7390
4.88
12.23
19.5
12.8
72.24
71.67
umol/l
0.15
794
7309
803
7418
4.98
11.93
13.7
9.5
28.23
27.20
u/l
0.81
792
7266
273
1829
1.74
11.76
1.5
1.4
2.09
2.16
g/l
0.32
157
1210
112
561
2.15
11.63
9.9
5.4
—
—
—
0
0
66
266
2.61
11.19
2.1
2.6
97.62
114.96
ng/l
0.22
58
234
102
504
2.17
10.95
2.1
1.6
370.41
292.13
mu/l
1.06
85
453
698
6106
1.96
10.73
6.4
4.7
37.36
37.42
mmol/mol
0.06
668
5887
122
653
2.02
10.60
7.3
7.3
104.22
104.73
mmol/l
0.59
122
653
91
454
2.13
9.51
5.1
3.4
2.35
1.67
mmol/l
1.01
84
394
754
6858
2.24
9.27
5.7
4.4
2.81
2.83
mmol/l
0.20
712
6587
230
1553
1.67
9.25
4.0
4.3
17.82
12.86
mg/mmol
0.29
136
993
361
2779
1.53
8.10
2.2
1.8
1.53
1.40
mmol/l
1.05
314
2465
77
385
2.10
8.00
1.5
2.0
2.80
3.39
mg/l
0.50
64
270
85
451
1.99
7.52
5.1
7.9
1.35
1.35
mmol/l
0.01
85
440
66
1252
0.49
7.49
1.6
1.8
3.36
3.52
ratio
0.43
53
937
521
5960
0.65
7.45
3.4
3.7
—
—
—
0
0
71
354
2.10
7.44
3.6
4.0
85.72
77.80
ng/l
0.33
64
320
742
6803
1.95
7.43
5.0
4.0
1.38
1.45
mmol/l
4.60
703
6534
743
6832
1.93
7.12
5.3
4.1
4.64
4.72
mmol/l
1.34
713
6581
521
4421
1.49
6.80
4.9
3.8
2495.00
1387.10
e6/l
0.17
12
49
155
1018
1.64
6.73
3.3
3.2
198.27
739.94
ng/l
1.75
89
599
52
1014
0.48
6.33
1.3
1.6
847.54
1007.64
mu/l
1.23
41
874
813
7890
4.56
6.13
28.2
17.2
265.44
258.47
e9/l
2.36
802
7777
35
140
2.57
6.10
1.6
2.7
1.47
2.37
index
0.46
17
77
128
820
1.66
6.09
2.0
1.7
—
—
—
0
0
14
21
6.76
6.05
1.9
2.3
14.46
16.37
umol/l
0.24
14
21
813
7895
4.49
5.98
28.0
17.1
4.61
4.60
e12/l
0.10
800
7775
813
7895
4.49
5.98
28.3
17.4
41.16
42.06
%
0.68
808
7833
813
7893
4.52
5.97
27.9
17.1
89.65
89.93
fl
1.08
808
7837
50
958
0.49
5.76
1.4
1.6
3.30
3.43
mmol/l
0.40
40
646
171
1193
1.55
5.70
2.5
2.6
81.02
105.92
ug/g
1.14
133
952
813
7901
4.39
5.66
28.3
17.2
137.26
137.86
g/l
0.65
808
7842
161
1111
1.56
5.63
2.6
3.0
1575.90
796.28
ng/l
0.46
125
893
76
432
1.84
5.50
1.5
1.4
—
—
—
0
0
38
170
2.30
5.24
1.6
1.4
484.35
305.58
ug/g
0.39
19
90
751
7041
1.79
5.17
16.1
11.2
20.81
20.85
mg/l
0.01
579
5631
69
389
1.84
5.13
1.5
1.6
—
—
—
0
0
177
1271
1.50
5.12
2.6
2.3
6.04
7.47
e6/l
0.69
163
1150
94
581
1.70
5.11
2.1
1.7
—
—
—
0
0
695
6398
1.57
5.05
4.2
3.5
1.41
1.25
mmol/l
6.37
656
6123
58
311
1.93
5.02
2.7
2.2
4.28
8.19
ug/l
1.60
50
279
36
162
2.28
4.91
1.7
1.4
400.22
355.25
mu/l
0.24
27
134
246
1905
1.42
4.75
3.0
2.7
28.44
50.00
e6/l
0.64
182
1414
112
738
1.60
4.75
2.2
2.4
8.64
6.55
umol/l
0.39
94
639
95
601
1.66
4.74
2.1
1.6
—
—
—
0
0
18
477
0.36
4.69
1.1
1.1
0.86
0.88
g/l
0.26
18
477
18
469
0.37
4.53
1.1
1.1
1.59
1.52
g/l
0.83
18
469
49
258
1.96
4.50
6.5
2.4
0.63
0.60
%
0.37
49
258
84
526
1.67
4.37
1.0
1.0
—
—
—
0
0
678
6263
1.48
4.28
20.7
13.7
13.40
13.26
%
2.50
672
6196
705
6581
1.51
4.05
12.8
9.9
97.42
94.51
ml/min/173m2
3.31
656
5907
18
444
0.39
4.02
1.9
1.8
—
—
—
0
0
11
22
5.05
4.01
1.0
1.2
75.74
71.18
nmol/24h
0.09
11
22
28
570
0.47
3.85
1.2
1.6
71.26
60.36
ug/l
0.32
23
488
24
511
0.45
3.74
1.1
1.5
—
—
—
0
0
48
269
1.83
3.69
2.3
2.4
1.32
1.36
mmol/l
0.02
31
184
15
385
0.38
3.69
1.8
1.6
58.68
59.93
ug/l
0.04
15
385
207
1631
1.36
3.47
2.6
2.7
0.31
0.30
e6/l
0.05
145
1151
77
501
1.59
3.47
2.4
3.9
4.40
4.67
pmol/l
2.02
70
457
26
522
0.48
3.46
1.1
1.5
1.45
1.16
ratio
0.34
12
322
26
522
0.48
3.46
1.1
1.5
0.91
0.93
ratio
0.10
12
322
26
522
0.48
3.46
1.1
1.5
1.13
1.20
ratio
0.19
12
322
37
660
0.54
3.41
1.5
1.5
—
—
—
0
0
53
321
1.70
3.17
1.7
1.8
—
—
—
0
0
196
1555
1.34
3.11
3.9
3.5
93.40
95.32
%
0.52
191
1518
98
691
1.48
3.08
2.6
2.4
11.04
13.61
nmol/l
2.17
86
656
20
422
0.46
3.08
1.4
1.9
—
—
—
0
0
189
1494
1.34
3.07
2.1
2.3
323.39
328.50
umol/l
0.31
176
1383
132
985
1.41
3.06
2.1
2.4
1.22
0.96
e6/l
0.22
63
477
25
481
0.50
2.96
1.5
1.7
—
—
—
0
0
91
641
1.47
2.88
4.2
3.6
31.92
31.30
%
0.21
76
471
7
13
5.42
2.87
23.0
2.8
5.30
4.58
kpa
—
7
13
7
13
5.42
2.87
23.0
2.8
10.73
11.68
kpa
—
7
13
17
72
2.39
2.74
1.1
1.4
—
—
—
0
0
106
779
1.41
2.69
1.7
1.9
28.66
29.03
s
0.37
101
761
16
67
2.42
2.64
1.1
1.1
—
—
—
0
0
33
186
1.81
2.56
1.7
2.0
—
—
—
0
0
30
164
1.86
2.56
3.1
1.9
3.94
2.94
ug/l
0.14
30
150
58
383
1.55
2.51
1.4
1.4
6.67
8.43
u/l
0.93
50
315
242
2036
1.27
2.43
4.0
2.8
58.08
75.27
ng/l
0.12
127
1024
422
3780
1.24
2.43
4.0
3.2
0.00
1.92
estimate
0.50
58
784
30
169
1.80
2.35
1.7
1.4
21.86
17.91
u/l
0.24
25
142
25
133
1.91
2.33
1.9
1.3
—
—
—
0
0
64
440
1.49
2.32
2.3
2.1
74.79
78.90
ml/min/173m2
0.28
29
185
19
92
2.09
2.28
1.3
1.3
—
—
—
0
0
12
47
2.58
2.28
2.3
1.5
19.29
6.82
ug/l
0.78
12
41
11
41
2.71
2.21
1.7
1.6
—
—
—
0
0
11
41
2.71
2.21
1.7
1.6
—
—
—
0
0
11
41
2.71
2.21
1.7
1.6
—
—
—
0
0
17
80
2.15
2.20
1.1
1.1
—
—
—
0
0
87
642
1.40
2.18
2.4
2.4
28.53
109.69
u/l
0.55
74
537
56
380
1.51
2.17
2.6
3.3
1.22
1.23
mmol/l
0.30
44
333
6
14
4.31
2.15
1.0
1.0
6.78
6.94
nmol/l
—
6
14
421
3801
1.22
2.15
4.1
3.3
0.00
0.01
estimate
0.80
52
741
56
382
1.50
2.12
1.5
1.4
—
—
—
0
0
30
175
1.74
2.12
1.6
1.9
—
—
—
0
0
164
1336
1.28
2.12
2.6
2.2
—
—
—
0
0
49
325
1.54
2.11
2.0
3.0
67.59
68.34
g/l
0.39
44
306
17
82
2.10
2.08
1.1
1.4
—
—
—
0
0
17
82
2.10
2.08
1.1
1.3
—
—
—
0
0
17
83
2.07
2.02
1.1
1.3
—
—
—
0
0
117
918
1.32
2.00
2.2
2.5
5.79
3.37
e6/l
0.63
47
412
16
78
2.07
1.92
1.1
1.4
—
—
—
0
0
44
292
1.54
1.91
1.8
1.4
—
—
—
0
0
92
702
1.35
1.90
2.4
2.3
2700.82
5925.07
u/l
0.75
21
291
12
52
2.33
1.88
1.2
1.7
—
—
—
0
0
16
79
2.05
1.86
1.1
1.4
—
—
—
0
0
16
79
2.05
1.86
1.1
1.4
—
—
—
0
0
27
161
1.70
1.80
1.2
1.3
2.53
16.49
e6/l
1.68
19
118
91
706
1.33
1.70
1.2
1.3
86.46
135.66
u/ml
1.05
31
274
27
164
1.67
1.70
1.3
1.3
1126.15
556.28
e6/l
0.19
20
127
16
291
0.54
1.67
1.4
1.3
—
—
—
0
0
21
119
1.78
1.67
1.2
1.2
—
—
—
0
0
7
25
2.81
1.65
1.7
2.3
0.57
1.84
%
—
7
25
74
561
1.35
1.62
1.6
1.4
14.33
19.31
iu/l
1.03
55
476
10
43
2.34
1.59
1.2
1.8
—
—
—
0
0
5
15
3.35
1.52
2.0
2.1
—
—
—
0
0
407
3754
1.17
1.42
4.1
3.2
0.00
0.00
estimate
0.50
60
789
31
206
1.52
1.39
1.1
1.3
—
—
—
0
0
24
150
1.62
1.39
1.7
1.5
—
—
—
0
0
20
319
0.62
1.33
2.0
1.6
—
—
—
0
0
19
113
1.70
1.32
2.2
1.3
—
—
—
0
0
133
1123
1.22
1.28
2.4
2.1
—
—
—
0
0
18
107
1.70
1.26
2.2
1.3
—
—
—
0
0
14
77
1.83
1.26
1.4
1.3
—
—
—
0
0
14
77
1.83
1.26
1.0
1.3
—
—
—
0
0
20
123
1.64
1.25
3.8
2.5
—
—
—
0
0
14
78
1.81
1.21
1.2
1.6
0.51
0.50
e9/l
0.03
14
78
5
20
2.51
1.15
1.8
1.4
10.14
8.55
ug/l
—
5
20
0
36
0.00
1.14
0.0
1.2
—
66.36
—
0
36
0
36
0.00
1.14
0.0
1.1
—
—
—
0
0
7
32
2.20
1.08
1.9
1.7
—
—
—
0
0
11
59
1.88
1.07
1.9
2.8
219.09
216.06
e6/l
0.03
11
52
11
60
1.84
1.03
2.5
1.5
—
—
—
0
0
150
1315
1.17
0.98
1.3
1.3
10.16
9.23
u/ml
0.05
41
543
215
1940
1.15
0.96
2.7
2.3
—
—
—
0
0
30
218
1.39
0.92
1.4
1.5
0.29
0.39
nmol/l
0.83
20
184
10
170
0.58
0.90
1.0
1.1
—
—
—
0
0
40
307
1.32
0.89
1.7
1.7
2.71
9.74
u/ml
—
8
92
61
745
0.80
0.88
2.4
2.4
0.54
0.66
ug/l
0.43
38
347
18
119
1.52
0.88
4.7
3.1
14.03
25.73
mg/l
—
10
77
10
56
1.80
0.88
8.4
5.9
11.42
9.88
mg/l
—
10
51
14
87
1.62
0.88
1.0
1.1
—
—
—
0
0
8
45
1.79
0.84
1.0
1.2
—
—
—
0
0
16
105
1.53
0.82
1.0
1.1
—
1.91
—
0
8
14
89
1.58
0.81
1.0
1.1
—
—
—
0
0
219
2007
1.12
0.77
4.6
3.2
0.00
0.01
estimate
1.28
59
753
25
183
1.38
0.76
1.1
1.3
—
—
—
0
0
19
133
1.44
0.74
1.2
1.1
1.00
143.13
iu/ml
—
6
35
5
26
1.93
0.70
1.0
2.7
2.01
1.25
ug/l
—
5
26
5
26
1.93
0.70
1.2
2.2
183.00
183.85
u/l
—
5
26
26
195
1.34
0.70
1.1
1.1
—
—
—
0
0
26
195
1.34
0.70
1.1
1.2
—
—
—
0
0
16
110
1.46
0.68
2.1
2.0
5.74
5.28
mmol/24h
0.19
16
103
9
59
1.53
0.68
1.6
2.6
453.00
580.22
e6/l
—
9
49
57
477
1.21
0.66
1.3
1.2
—
38.84
—
0
29
310
2917
1.10
0.66
4.0
3.0
0.00
0.02
estimate
1.64
47
663
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
8
129
0.62
0.64
1.4
1.2
—
—
—
0
0
20
147
1.37
0.62
1.5
1.4
—
—
—
0
0
8
49
1.64
0.62
2.0
2.7
—
—
—
0
0
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
12
80
1.51
0.60
1.0
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
171
1576
1.11
0.55
1.7
1.7
0.84
0.92
mg/l
0.26
122
1150
41
492
0.82
0.55
1.5
1.4
230.71
239.08
miu/ml
0.04
16
253
225
2105
1.09
0.54
2.7
2.4
—
—
—
0
0
157
1443
1.11
0.54
1.4
1.3
24.84
26.23
iu/ml
0.06
48
414
15
204
0.73
0.53
1.1
1.0
0.95
0.34
u/ml
—
5
68
9
62
1.46
0.53
1.0
1.1
111.00
111.68
pmol/l
—
9
62
10
66
1.52
0.52
1.1
1.3
—
—
—
0
0
9
64
1.41
0.51
2.3
1.2
—
209.23
—
0
13
16
118
1.36
0.50
3.9
2.8
7.41
8.01
pmol/l
0.10
16
118
214
2277
0.92
0.48
3.1
2.7
0.00
0.02
estimate
1.74
48
655
11
76
1.45
0.48
1.0
1.1
—
—
—
0
0
69
608
1.15
0.48
1.4
1.3
111.70
400.33
u/ml
1.31
61
571
32
264
1.22
0.46
1.5
1.5
—
—
—
0
0
20
252
0.79
0.44
1.1
1.1
0.34
2.50
u/ml
3.46
12
127
6
95
0.63
0.42
1.0
1.6
—
1001.42
—
0
14
22
176
1.26
0.42
1.2
1.3
—
1.43
—
0
12
10
70
1.43
0.42
1.0
1.2
—
—
—
0
0
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
1.41
—
0
16
0
16
0.00
0.41
0.0
4.6
—
—
—
0
0
0
17
0.00
0.40
0.0
1.8
—
—
—
0
0
0
17
0.00
0.40
0.0
1.8
—
—
—
0
0
0
17
0.00
0.40
0.0
1.8
—
—
—
0
0
5
34
1.47
0.40
1.0
1.3
118.40
88.69
nmol/l
—
5
24
133
1237
1.09
0.38
3.4
3.6
1.21
1.67
ug/l
0.99
121
1149
10
72
1.39
0.37
1.0
1.2
—
—
—
0
0
9
71
1.27
0.36
1.0
1.2
—
—
—
0
0
9
71
1.27
0.36
1.0
1.1
—
—
—
0
0
5
78
0.64
0.35
1.0
1.4
—
—
—
0
0
9
122
0.73
0.35
2.6
1.9
0.00
0.00
g/l
—
9
114
10
73
1.37
0.34
1.0
1.2
—
—
—
0
0
312
3235
0.94
0.34
3.1
2.6
—
—
estimate
—
0
0
6
45
1.34
0.34
4.0
4.2
432.67
618.02
u/ml
—
6
45
10
133
0.75
0.33
1.8
1.2
—
—
—
0
0
59
532
1.12
0.32
1.3
1.4
—
—
—
0
0
12
92
1.31
0.32
1.3
1.8
—
—
—
0
0
14
110
1.28
0.32
3.3
3.9
32.79
33.11
mg/l
0.01
14
95
7
99
0.70
0.31
1.4
1.2
—
—
—
0
0
12
94
1.28
0.28
1.6
1.5
—
—
—
0
0
11
85
1.30
0.28
1.0
1.2
—
—
—
0
0
9
72
1.25
0.25
1.2
1.4
143.04
169.06
pmol/l
—
9
72
5
39
1.28
0.23
1.0
1.1
0.16
2.73
u/ml
—
5
39
5
39
1.28
0.23
2.2
4.2
1055.20
1628.64
mg
—
5
39
5
40
1.25
0.22
1.0
1.2
—
93.83
—
0
6
5
42
1.19
0.21
1.8
2.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
12
98
1.23
0.21
1.2
1.3
—
—
—
0
0
12
98
1.23
0.21
1.2
1.3
—
—
—
0
0
8
101
0.79
0.21
1.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
37
335
1.11
0.21
1.3
2.1
15.56
5.39
iu/ml
—
7
76
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
24
211
1.14
0.21
1.6
1.5
—
—
—
0
0
11
134
0.82
0.20
4.1
2.2
0.17
0.84
g/l
1.01
11
123
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
9
115
0.78
0.20
2.6
1.9
0.00
0.00
g/l
—
9
104
222
2285
0.96
0.18
1.9
1.7
—
—
—
0
0
13
110
1.18
0.17
3.5
3.9
24.50
28.06
mg/l
0.29
13
94
15
129
1.17
0.17
3.0
1.9
9.91
10.39
g/l
0.18
15
122
8
69
1.16
0.16
1.0
1.2
—
—
—
0
0
8
70
1.14
0.16
1.0
1.3
—
—
—
0
0
12
140
0.86
0.15
1.9
1.5
—
—
—
0
0
26
286
0.91
0.15
1.2
1.1
0.13
3.77
u/ml
4.69
13
147
164
1594
1.04
0.13
1.7
1.5
—
—
—
0
0
20
222
0.90
0.13
1.3
2.2
5.70
4.71
umol/l
0.35
13
171
101
972
1.04
0.13
3.3
3.3
20.78
22.30
%
0.27
22
308
9
109
0.82
0.13
2.6
1.9
0.00
0.00
g/l
—
9
104
24
219
1.10
0.12
1.2
1.2
—
53.03
—
0
6
42
394
1.07
0.12
2.5
4.6
5.85
17.23
ug/l
0.49
31
308
18
198
0.91
0.10
1.6
1.9
—
—
—
0
0
24
259
0.92
0.10
1.1
1.1
8.25
7.11
u/ml
0.10
14
153
5
44
1.14
0.10
4.2
1.9
1.22
1.19
mmol/l
—
5
44
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
5
44
1.14
0.10
4.2
1.9
103.40
105.61
mmol/l
—
5
44
157
1605
0.97
0.09
2.9
2.0
—
—
—
0
0
5
47
1.06
0.09
1.0
1.7
—
—
—
0
0
13
145
0.89
0.09
1.1
1.2
1.83
3.89
u/ml
—
6
53
20
184
1.09
0.09
1.5
1.3
—
—
—
0
0
52
499
1.04
0.08
2.8
2.5
—
—
—
0
0
13
143
0.91
0.07
1.1
1.3
3.57
4.50
u/ml
—
7
62
9
84
1.07
0.07
1.1
1.6
—
—
—
0
0
23
244
0.94
0.06
2.5
2.3
2.58
4.56
iu/l
1.40
12
106
22
207
1.06
0.06
1.3
1.3
255.17
231.71
u/ml
0.14
12
126
10
90
1.11
0.05
1.4
3.3
6.07
7.57
u/ml
—
10
90
16
149
1.08
0.05
2.9
2.0
7.06
7.16
g/l
0.10
16
143
16
149
1.08
0.05
2.9
2.0
4.55
4.36
g/l
0.42
16
143
16
149
1.08
0.05
2.9
2.0
3.64
3.70
g/l
0.08
16
143
24
228
1.05
0.05
1.3
1.3
—
3.05
—
0
21
13
120
1.08
0.05
1.5
3.3
—
3188.11
—
0
9
19
180
1.06
0.04
1.4
1.4
115.16
171.42
pmol/l
0.25
19
174
36
350
1.03
0.03
1.4
1.4
—
—
—
0
0
12
113
1.06
0.02
1.3
1.3
—
223.64
—
0
11
12
127
0.94
0.01
1.3
1.4
—
—
—
0
0
14
143
0.98
0.00
3.0
2.0
2.60
2.85
g/l
0.88
14
137
24
243
0.99
0.00
1.3
1.2
—
16.85
—
0
11
14
142
0.99
0.00
1.1
1.1
—
—
—
0
0
10
99
1.01
0.00
1.2
1.2
97.60
95.58
%
—
10
91
14
141
0.99
0.00
2.1
2.0
—
1777.78
—
0
9
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
2.1
—
17.60
—
0
7
0
7
0.00
0.00
0.0
5.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
26.50
—
0
5
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.2
—
13.47
—
0
6
8
80
1.00
-0.00
1.1
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
8.67
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.3
—
10.12
—
0
6
5
53
0.94
-0.00
1.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_ANXPER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_ANXPER | 2.031 [1.64, 2.51] | < 0.001 |
| Birth year | 0.994 [0.98, 1.0] | 0.235 |
During the follow-up period (1.1.1998 — 31.12.2019), 110 out of 2540 females with F5_ANXPER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_ANXPER | 2.306 [1.95, 2.72] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.029 |
During the follow-up period (1.1.1998 — 31.12.2019), 215 out of 2580 males with F5_ANXPER died.
Mortality risk
Mortality risk for people of age
years, who have F5_ANXPER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.19% | 0.533% |
| 5 | 1.135% | 2.685% |
| 10 | 2.929% | 6.836% |
| 15 | 5.855% | 13.274% |
| 20 | 10.102% | 22.534% |
Relationships between endpoints
↥Index endpoint: F5_ANXPER – Anxious personality disorder
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data